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Abstract
Objective: The label and detection of cells injected into target tissues is an area of focus 
for researchers. Iron oxide nanoparticles can be used to label cells as they have special 
characteristics. The purpose of this study is to examine the effects of iron oxide nanoparti-
cles on human-derived amniotic membrane stem cell (hAMCs) survival and to investigate 
the magnetic properties of these nanoparticles with increased contrast in magnetic reso-
nance imaging (MRI).      
Materials and Methods: In this experimental study, we initially isolated mesenchymal 
stem cells from amniotic membranes and analyzed them by flow cytometry. In addition, 
we synthesized superparamagnetic iron oxide nanoparticles (SPIONs) and characterized 
them by various methods. The SPIONs were incubated with hAMCs at concentrations of 
25-800 μg/mL. The cytotoxicity of nanoparticles on hAMCs was measured by the MTT as-
say. Next, we evaluated the effectiveness of the magnetic nanoparticles as MRI contrast 
agents. Solutions of SPION were prepared in water at different iron concentrations for 
relaxivity measurements by a 1.5 Tesla clinical MRI instrument.     
Results: The isolated cells showed an adherent spindle shaped morphology. Polyeth-
ylene glycol (PEG)-coated SPIONs exhibited a spherical morphology. The average par-
ticle size was 20 nm and magnetic saturation was 60 emu/g. Data analysis showed no 
significant reduction in the percentage of viable cells (97.86 ± 0.41%) after 72 hours at 
the 125 μg/ml concentration compared with the control. The relaxometry results of this 
SPION showed a transverse relaxivity of 6.966 (μg/ml.s)-1                     
Conclusion: SPIONs coated with PEG used in this study at suitable concentrations 
had excellent labeling efficiency and biocompatibility for hAMCs.            
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Introduction
Cell therapy has been suggested as the best way 
to treat most diseases. Thus far, a wide range of 
stem cells has been employed to enhance tissue 
damage repair in animal as well as human tissues. 
Amniotic membrane stem cells are particularly in-
teresting because of their ease of preparation, lack 
of stimulation of the immune system, high potency 
for differentiation, and secretion of growth and 
anti-inflammatory factors (1).
In addition to the cell type, tracking the cell af-
ter injection into the target tissue plays an impor-
tant role in cell therapy (2). Although numerous 
methods are used to detect these cells, iron oxide 
nanoparticles are most common because they can 
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enter cells without intervention and are nontoxic 
at certain concentrations (3). Because of their high 
sensitivity and appropriate size, iron oxide nano-
particles are used as contrast agents in magnetic 
resonance imaging (MRI) (2).
MRI is recognized as a commonly used, strong 
diagnostic technique in medical fields. It is non-
invasive, easy to use, and has a high penetration 
to obtain detailed internal cross-sectional images 
of living organisms (4). Biological tissues have 
aqueous environments. The signal intensity of 
MRI depends on the local values of longitudinal or 
transverse relaxation rate of water protons (5). Ap-
plication of contrast agents plays a significant role 
by enhancing the contrast between tissue types by 
increasing the image quality, which therefore in-
creases the sensitivity of the MRI method (6, 7). 
Two different classes are used as contrast agents 
in MRI-T
1
 agents that decrease proton longitu-
dinal relaxation time providing positive contrast 
(gadolinium complexes or manganese ions) and 
T
2 
agents that truncate proton transverse relaxation 
time providing negative contrast (iron oxide na-
noparticles). Superparamagnetic iron oxide nano-
particles (SPIONs), are relatively safe T
2
 contrast 
agents for MRI with excellent sensitivity (8, 9).
 Because of their unique characteristics nanopar-
ticles are used for cell detection. However some 
studies suggest that these nanoparticles decrease 
cell proliferation, induce apoptosis, inflammation, 
DNA damage, and oxidative stress in cells (10-
12). The toxicity of SPION is strongly associated 
with the dose and coating of these nanoparticles. 
The choice of more biocompatible materials for 
coating the magnetic nanoparticles can resolve 
the problem of cytotoxicity (13, 14). In order to 
decrease the cytotoxic effects of nanoparticles, it 
is possible to coat their surface with various poly-
mers and biomolecules (15). Polyethylene glycol 
(PEG) is one of the preferred materials for coating 
magnetic nanoparticles due to its high bio-stability 
and very low toxicity. PEG has extensive applica-
tions in medicine (16, 17).
In this study, we used an appropriate dose of a 
PEG-coated SPION, a biocompatible coat, to label 
amniotic membrane stem cells. We investigated 
the role of SPION in terms of MRI quality. The 
results of this study might help to use MRI as a 
monitor of labeled hAMCs injected into damaged 
tissues for possible future use in cell therapy.
Materials and Methods
Synthesis and characterization of superpara-
magnetic iron oxide nanoparticles 
In this experimental study, we synthesized SPI-
ON samples by co-precipitation. SPIONs were 
synthesized by deposition of alkaline salts of iron 
ions through a single-step process.
First, the hydrated iron chlorides, FeCl
2
.4HO
2 
and FeCl
3
.6HO
2
 were dissolved in distilled water 
at a 2:1 ratio, using a stirrer and deoxidized by 
nitrogen at room temperature. Then, ammonium 
hydroxide was dropped into this solution, while 
under stirring conditions and the pH increased to 
11. The addition of ammonium hydroxide result-
ed in a brown sediment which was removed by 
a magnet after 30 minutes of stirring. Sediment 
has been rinsed and separated several times by 
distilled water and ethanol. It was dried at room 
temperature after two acetone washes. In order to 
determine the particle size and morphology, we 
used high resolution transmission electron mi-
croscopy (HR-TEM). The particles were coated 
with 3-amino propyl tri ethoxyl silane (APTES) 
so that carboxyl polyethylene could bind to the 
surface amine. We investigated the magnetic 
property by using vibrating sample magnetom-
eter (VSM).
Informed consent   
We obtained written permission from pregnant 
women who were hospitalized in Milad Hospital, 
Tehran, Iran. Participants were informed about the 
research study and were assured that there would 
be no harm to their delivery process.
Cell culture   
We confirmed the presence of these stem cells by 
performing differential tests. Cells were extracted 
from the newborns’ amniotic sacs as published in 
our previous study (18). The cells were maintained 
in complete Dulbecco’s Modified Eagle’s Medium 
(DMEM) supplemented with 10% fetal bovine se-
rum (FBS), NaHCO
3
 (3.7 g/l), penicillin (100 U/
ml), and streptomycin (100 mg/ml, Sigma, USA). 
Cells were then grown in a humidified atmosphere 
of 5% CO
2
 and 95% air in an incubator at 37˚C. 
When the cells reached 70-80% confluency, they 
were used for labeling with SPIONs.
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Cell characterization by flow cytometry 
In order to ensure that the isolated cells were mesen-
chymal cells, we performed flow cytometric analyses. 
Cells were stained with specific antibodies for flow 
cytometry. In brief, cultured hAMCs were washed 
twice in phosphate-buffered saline (PBS) and harvest-
ed with 0.25% trypsin/EDTA (Invitrogen, USA). The 
cells were then washed with PBS and divided into 
aliquots for antibody staining. Each aliquot contained 
approximately 5×103 cells. The antibodies were used 
to detect the following cell surface antigens: CD44, 
CD29, CD90, CD73, CD105, CD166, CD45, CD34, 
and CD14. All antibodies were conjugated with fluo-
rescein isothiocyanate and phycoerythrin. The cells 
were stained at 4˚C for 30 minutes. After the incubas-
tion period, the cells were washed with PBS and re-
suspended in 500 μL of PBS. Analysis was performed 
with a FACSCalibur flow cytometer (Becton Dickin-
son, USA).
Cytotoxicity investigation 
We performed MTT analysis to find the appropri-
ate dose of nanoparticles on the cells. After trypsini-
zation and cell counting, we added 5000 cells added 
to each well of 96-well microplates. After 24 hours, 
nanoparticles at concentrations of 0, 25, 50, 75, 100, 
125, 150, 175, 200, 400, 600, and 800 μg /mL were 
added to the wells, and the plates were incubated for 
24, 48 and 72 hours. Then, the culture medium that 
included SPIONs was changed and the medium was 
washed three times by PBS, each time for 5 minutes 
in order to remove the nanoparticles from outside the 
cells and within the wells. Only nanoparticles located 
inside the cells were allowed to remain. Then, we dis-
solved 10 mg of tetrazolium powder in 2 ml of PBS. 
Of this solution, 150 μL was added to each well. The 
mixture was incubated in a CO
2 
incubator at 37˚C for 
4 hours. Next, 100 μL of dimethyl sulfoxide (DMSO, 
Sigma, USA) was added, and after 10 minutes the 
light absorption of the resultant solution was ob-
served by an ELISA Reader at 570 to 630 nm. We 
determined the percentage of viable cells calculated 
according to the control absorption ratio.
Intracellular uptake of superparamagnetic iron 
oxide nanoparticles  
We investigated nanoparticles diffusion into the 
cells by MRI. In order to determine the appropriate 
concentration for imaging the cells were incubated 
with various concentrations of nanoparticles (50, 100, 
150, 200, 250, 300, 350, 400, 450, 500 μg/ml) and 
fixed in a 2% agarose gel. The 1.5 T MRI scanners 
with knee coils were used as follows: echo-times (TE) 
that ranged from 13 milliseconds to 132, TR of 3000 
milliseconds, field of view (FOV) of 23 cm, 8 mm 
slice thickness, and acquisition matrix of 256×256.
Magnetic resonance imaging relaxometry
Relaxometry refers to the measurement of relaxa-
tion variables in an MRI in order to determine the spe-
cific physical and chemical properties of materials. 
Solutions of SPION-PEG were prepared in water at 
iron concentrations of 0.3, 0.63, 1, 1.5, and 2.5 µg/ml 
for the relaxivity measurements. All measurements 
were made at room temperature with a 1.5 T MRI 
clinical scanner (MAGNETOM Avanto, Siemens). 
T
2
 relaxivity was determined at 1.5 T using spin-echo 
acquisition that utilized 32 TE, with a range from 13 
to 132 milliseconds, and repetition time (TR) of 3000 
milliseconds.
The ability of a contrast agent to enhance the 
proton relaxation rate was determined by the re-
laxivity (ri) that decreased the longitudinal and 
transverse relaxation times. The equation for the 
relativity of each contrast agent is:
1
T
1, 2
1
T
1, 2
= +R1, 2 R0 r1, 2 C= (      ) (    )0
where T
1
 and T
2
 are longitudinal and transver-
sal relaxations, R
0
 is the relaxation rate without 
the presence of the contrast agent, C is the con-
centration (molarity) of the contrast agent and  is 
the relaxivity constant of the agent. The relaxivity 
of different concentrations of nanoparticles were 
calculated by linear curve fitting of the relaxation 
rates R
1, 2
 1
T
1, 2
(      ) . Therefore, the slope of this curve 
was r
1, 2
.
T
2
 values were obtained by fitting a logarithmic 
curve of the mean measured MR signal in a region 
of interest versus TE. The associated relaxivities (r
2
 in 
(μg/ml.second)-1 were obtained from a linear curve of 
the slopes of  1
T
 2
versus the Fe concentration. These 
calculations were performed using Excel software.
Other scan parameters were as follows: field of 
view (23 cm), slice thickness (8 mm), and acquisition 
matrix (256×256).
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Statistical analysis 
The results were presented as mean ± SD from 
three replicates of each experiment. Statistical 
analyses were performed with SPSS 21.0 software. 
Representative data were analyzed for statistical 
significance by one-way ANOVA with post hoc 
Bonferroni correction for multiple comparisons. 
A P value of less than 0.05 was considered statis-
tically significant. In order to obtain relaxometry, 
the results were analyzed and plots drawn using 
Radiant application, MATLAB (version 1.0.01), 
and Microsoft Excel 2010.
Ethical considerations 
This study received the approval of the Ethics 
Committee of Iran University of Medical Sciences.
Results
Synthesis and characterization of superparamagnetic 
iron oxide nanoparticles 
The resultant SPION samples had a spherical 
morphology and average particle size of 20 nm 
(Fig.1). Figure 2 shows the hysteresis loop of nan-
oparticles as determined by vibrating sample mag-
netometer VSM that is a scientific instrument that 
measures magnetic properties.
These particles showed the superparamagnet-
ism effect. Magnetic properties showed that the 
coating decreased the magnetic saturation from 60 
emu/g to 40 emu/g (Fig.2). 
Fig.1: Spherical shape of a synthesized iron oxide nanoparticle 
under an electron microscope.
Fig.2: Graph for superparamagnetic behavior of superparamagnetic 
iron oxide nanoparticles (SPIONs) measured at room temperature. 
A. Magnetic property of iron oxide nanoparticles without coating 
and B. Magnetic property of iron oxide nanoparticles coated by poly-
ethylene glycol (PEG).
Cell culture 
We successfully isolated and cultured mesenchy-
mal cells from the placental amniotic membrane. 
At first, the cells had a round shape, which pro-
gressed to an elongated shape, and finally a typical 
fibroblastic morphology (Fig.3).
Flow cytometry 
After cell extraction, we studied the mean fre-
quency of the CD44, CD29, CD90, CD73, CD105, 
CD166, CD45, CD34, and CD14 markers (Fig.4). 
Flow cytometry results showed that the most fre-
quent surface markers of the amniotic membrane 
stem cells were CD29 (99 ± 1) and CD166 (98 
± 2). The least frequent markers were CD45 (18 
± 11), CD14 (2.5 ± 0.5), and CD34 (1.4 ± 0.7) 
(Fig.4). 
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Fig.3: Fifth passage stem cells isolated from the amniotic 
membrane (×200 magnification).
Fig.4: Percentage of markers present in human amniotic mem-
brane mesenchymal stem cells (hAMCs).
Investigation of cytotoxicity  
MTT results showed 99.96 ± 0.05% cell viabil-
ity at the lowest concentration (25 μg/mL). Cell 
viability had a dose-dependent decrease with in-
creased concentrations of the nanoparticles. The 
nanoparticle cytotoxicities did not significantly 
differ with control cells during 24 hours at a con-
centration of 150 μg/mL and 97.26 ± 0.58% viable 
cells, 48 hours at 125 μg/mL and 98 ± 0.43% vi-
able cells, and 72 hours at 125 μg/mL and 97.86 ± 
0.41% viable cells. However the percentage of vi-
able cells after treatment with SPION significantly 
decreased in hAMCs at 150 μg/ml and higher. A 
strong association existed with dose and time in 
terms of SPION toxicity (Fig.5).
Fig.5: Cell viability of human-derived amniotic membrane stem 
cells (hAMCs) after exposure to various concentrations of super-
paramagnetic iron oxide nanoparticles (SPIONs, 0, 25, 50, 75, 
100, 125, 150, 175, 200, 400, 600, and 800 μg/mL) for 24, 48 and 
72 hours. Data are expressed as means ± SD from three experi-
ments as % of control cells.
Magnetic resonance imaging results for the cells 
In order to examine the nanoparticle effects 
on cells via MRI, we incubated the cells at dif-
ferent concentrations to show both nanoparticle 
diffusion and the concentration in which the best 
images could be obtained. Figure 6 shows that 
concentrations greater than 300 μg/ml had arti-
facts that were not good for the imaging process. 
Therefore, we considered the cells with concen-
trations below this level.
Fig.6: Magnetic resonance imaging (MRI) of stem cells incu-
bated with different concentrations of iron oxide nanoparti-
cles (1.5 T).
Relaxometry measurements  
Figure 7 shows the decrease in transverse relaxa-
tion time in terms of concentration. The declining 
rate of transverse relaxation time will increase with 
increasing concentrations of nanoparticles, result-
ing in a signal attenuation of MRI in the presence 
of the nanoparticles. The relaxometry results have 
PEG, Cytotoxic
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demonstrated that iron oxide nanoparticles coated 
by PEG showed good relaxometry for MRI and 
appropriate stability (Fig.8).
Fig.7: Magnetic resonance imaging (MRI) of different concentra-
tions of iron oxide nanoparticles (1.5 T).
Fig.8: The declining rate of transverse relaxation time in different 
concentrations of magnetized nanoparticles.
According to this formula:  1T
2
= +1
T
2int
rC
C; Concentration of iron oxide nanoparticles, 1/T
2
; Transverse 
relaxation time with the presence of nanoparticles, 1/T
2int
; Trans-
verse relaxation time of intrinsic water and r; Relaxometry.
According to this formula: y=ax+b
a; Slope of this curve (6.966) and b; Intercepts of this curve 
(7.2323).
Discussion
Recently, for cell therapy in addition to the cell 
type, researchers have expressed a particular inter-
est in their post-injection monitoring. The best ap-
proach for monitoring cells is to label them before 
they are injected into the target tissues (19, 20). 
Currently, substantial interest in using magnetic 
nanoparticles exists in order to label and track cells 
because these nanoparticles are efficient, biocom-
patible and have been approved by the Food and 
Drug Administration (FDA) (21). In some cases, 
the cytotoxicity of iron oxide nanoparticles has 
been reported. This cytotoxicity is associated with 
the nanoparticle surface coating, morphology, and 
cell type (12, 22, 23). In order to obtain a nontoxic 
nanoparticle, numerous studies have been con-
ducted on various cells treated by these nanopar-
ticles with certain characteristics (24). Berry et al. 
(25) treated human fibroblast cells with dextran 
coated iron oxide nanoparticles at a concentra-
tion of 50 μg/mL and 15 nm in diameter for three 
days. They observed decreased cell proliferation 
and cell death. Pawelczyk et al. (26) treated human 
macrophage cells with dextran coated iron oxide 
nanoparticles (100 μg/mL) that were 150 nm in 
diameter for seven days. In this study, only 20% 
of the cells survived. Naqvi et al. (27) treated rat 
macrophage cells with Tween 80 coated iron oxide 
nanoparticles at concentrations of 25-500 μg/mL 
and 30 nm in diameter for 1 to 6 hours.
The results showed that cell damage was related 
to dose and time. Mahmoudi et al. (28) treated rat 
cells (L929) with multiple concentrations of poly-
vinyl alcohol iron oxide nanoparticles (diameter: 
82 nm) for three days. They reported a relationship 
between cell damage to dose and size. Kunzmann 
et al. (29) treated human macrophage and dendritic 
cells with multiple concentrations of silica coated 
iron oxide nanoparticles (diameter: 120-130 nm) 
for two days. The results showed that cell damage 
was related to dose and size. Singh Gaharwar and 
Paulraj (30) treated rat peripheral blood cells with 
multiple concentrations (7.5-30 mg/kg) of iron 
oxide nanoparticles that were 30 nm in diameter 
for one week. They reported that with a decrease 
in anti-oxidants, the nanoparticles induced oxida-
tive stress and inflammation in the cells. However 
DNA damage was not significant in terms of cell 
exposure to the nanoparticles. According to these 
studies it could be concluded that the size and coat-
ing of nanoparticles as well as cell type determined 
the cytotoxicity levels of the nanoparticles. Many 
studies showed that iron oxide nanoparticle char-
acteristics such as high relaxivity, high sensitivity 
and superparamagnetism, which reduce relaxation 
as well as T
1
 and T
2
 times, made them suitable con-
trast agents for MRI. Some studies reported that 
iron oxide nanoparticle cytotoxicity was less than 
other contrast agents. It was possible to change 
the magnetic field by manipulating the size and 
coating of these nanoparticles (19). In the current 
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study, we have sought to examine the effects of 
iron oxide nanoparticles on hAMC viability be-
cause these cells are a substantial source for cell 
therapy due to their lack of ethical concerns, sim-
ple and economical preparation procedure, growth 
factors, anti-inflammatory factor excretion, and 
the ability to differentiate into other tissues (1). In 
order to decrease the cytotoxic effects, we coated 
these nanoparticles with PEG since various stud-
ies have shown that nanoparticles without biocom-
patible coatings are cytotoxic (12, 23). We have 
treated these cells with multiple concentrations of 
the nanoparticles. Our results showed that these 
nanoparticles were not cytotoxic in the range of 
150 μg/ml. Above this range the percentage of cell 
viability considerably diminished compared to the 
control group. This study used MRI to demon-
strate that the nanoparticles were absorbed into the 
cells through endocytosis without the need for any 
transfectant agent (30). The relaxometry results 
showed the efficiency of these nanoparticles as the 
contrast agent in MRI which has been confirmed 
by other studies (31-33). In terms of the nanopar-
ticles’ effects on cell survival and MRI results, we 
found that with appropriate concentrations, iron 
oxide nanoparticles coated with PEG could be 
used to label and detect the cells for MRI. 
Conclusion
In terms of the effects of iron oxide nanoparti-
cles on cell viability, it can be concluded that na-
noparticle cytotoxicity increases with increasing 
the concentration. The results of the current study 
have shown that PEG-coated iron oxide nanopar-
ticles at suitable concentrations have excellent la-
beling efficiency and biocompatibility for hAMCs. 
The data have shown that because of their high R
2 
relaxivity, iron oxide nanoparticles can be used as 
contrast agents in MRI and for cell detection. 
Acknowledgments
This article conducted and supported by the 
Physiology Research Center of Iran Medical Uni-
versity. All authors declare that they have no con-
flicts of interests.
References
1. Shahraki S, Jalali H, Parivar K, Hayati Roudbari N, Nabiu-
ni M, Heidari Z. Neuronal differentiation of mouse amnion 
membrane derived stem cells in response to neonatal 
brain medium. Journal of Cell and Molecular Research. 
PEG, Cytotoxic
2014; 6(2): 76-82. 
2. Li M, Gu H, Zhang C. Highly sensitive magnetite nano 
clusters for MR cell imaging. Nanoscale Res Lett. 2012; 
7(1): 204.
3. Budde MD, Frank JA. Magnetic tagging of therapeutic 
cells for MRI. J Nucl Med. 2009; 50(2): 171-174.
4. Szpak A, Fiejdasz S, Prendota W, Straczek T, Kapusta 
C, Szmyd J, et al. T1-T2 dual-modal MRI contrast agents 
based on superparamagnetic iron oxide nanoparticles 
with surface attached gadolinium complexes. J Nanopart 
Res. 2014; 16(11): 2678.
5. McMahon K, Cowin G, Galloway G. Magnetic resonance 
imaging: the underlying principles. J Orthop Sports Phys 
Ther. 2011; 41(11): 806-819.
6. Koenig SH, Gillis P. Transverse relaxation (1/T2) of sol-
vent protons induced by magnetized spheres and its rel-
evance to contrast enhancement in MRI. Invest Radiol. 
1988; 23 Suppl 1: S224-228.
7. Strijkers GJ, Mulder WJ, Van Tilborg GA, Nicolay K. MRI 
contrast agents: current status and future perspectives. 
Anticancer Agents Med Chem. 2007; 7(3): 291-305.
8. Li L, Jiang W, Luo K, Song H, Lan F, Wu Y, et al. Super-
paramagnetic iron oxide nanoparticles as MRI contrast 
agents for non-invasive stem cell labeling and tracking. 
Theranostics. 2013; 3(8): 595-615. 
9. Riyahi-Alam S, Haghgoo S, Gorji E, Riyahi-Alam N. Size 
reproducibility of gadolinium oxide based nanomagnetic 
particles for cellular magnetic resonance imaging: effects 
of functionalization, chemisorption and reaction condi-
tions. Iran J Pharm Res. 2015; 14 (1): 3-14
10. Soenen SJ, Nuytten N, De Meyer SF, De Smedt SC, De 
Cuyper M. High intracellular iron oxide nanoparticle con-
centrations affect cellular cytoskeleton and focal adhesion 
kinase-mediated signaling. Small. 2010; 6(7): 832-842.
11.  Lei L, Ling-Ling J, Yun Z, Gang L. Toxicity of superpara-
magnetic iron oxide nanoparticles: research strategies 
and implications for nanomedicine. Chin Phys B. 2013; 
22(12): 127503.
12. Singha N, Jenkinsa GJS, Asadib R, Doak SH. Potential 
toxicity of superparamagnetic iron oxide nanoparticles 
(SPION). Nano Rev. 2010; 1.
13. Yang WJ, Lee JH, Hong SC, Lee J, Lee J , Han DW. 
Difference between toxicities of iron oxide magnetic na-
noparticles with various surface-functional groups against 
human normal fibroblasts and fibrosarcoma cells. Materi-
als. 2013; 6(10): 4689-4706.
14. Friedrich RP, Janko C, Poettler M, Tripal P, Zaloga J, Ci-
cha I, et al. Flow cytometry for intracellular SPION quan-
tification: specificity and sensitivity in comparison with 
spectroscopic methods. Int J Nanomedicine. 2015; 10: 
4185-4201.
15. Seyedsadjadi M, Babaei SE, Farhadyar N. Preparation of 
surface modified magnetic Iron Oxide nanoparticles and 
study of their colloidal behavior. Int J Nano Dimens. 2014; 
5(3): 279-284.
16. Wu W, He Q, Jiang C. Magnetic iron magnetic iron ox-
ide nanoparticles: synthesis and surface functionalization 
strategies. Nanoscale Res Lett. 2008; 3(11): 397-415.
17. Chiper M, Hervé Aubert K, Augé A, Fouquenet JF, Soucé 
M, Chourpa I. Colloidal stability and thermo-responsive 
properties of iron oxide nanoparticles coated with poly-
mers: advantages of Pluronic® F68-PEG mixture. Nano-
technology. 2013; 24(39): 395605. 
18. Naseroleslami M, Parivar K, Khoei S, Aboutaleb N. Op-
timal concentration of PEG-coated Fe3O4 nanoparticles 
for generation of reactive oxygen species in human-de-
rived amniotic membrane stem cells.  Adv Stud Biol. 2015; 
7(8): 377-388.
CELL JOURNAL(Yakhteh), Vol 18, No 3, Oct-Dec (Autumn) 2016 339
Naseroleslami et al.
19. Bull E, Madani SY, Sheth R, Seifalian A, Green M, Sei-
falian AM. Stem cell tracking using iron oxide nanoparti-
cles. Int J Nanomedicine. 2014; 9: 1641-1653.
20. Hachani R, Lowdell M, Birchallc M, Thanh NT. Tracking 
stem cells in tissue-engineered organs using magnetic 
nanoparticles. Nanoscale. 2013; 5(23): 11362-11373.
21. Howell M, Wang C, Mahmoud A, Hellermann G, Mohapa-
tra SS, Mohapatra S. Dual-function theranostic nanopar-
ticles for drug delivery and medical imaging contrast: per-
spectives and challenges for use in lung diseases. Drug 
Deliv Transl Res. 2013; 3(4): 352-363. 
22. Mahmoudi M, Hofmann H, Rothen-Rutishauser B, Petri-
Fink A. Assessing the in vitro and in vivo toxicity of super-
paramagnetic iron oxide nanoparticles. Chem Rev. 2011; 
112 (4): 2323-2338.
23. Yu M, Huang S, Yu KJ, Clyne AM. Dextran and polymer 
polyethylene glycol (PEG) coating Reduce both 5 and 30 
nm iron oxide nanoparticle cytotoxicity in 2D and 3D cell 
culture. Int J Mol Sci. 2012; 13: 5554-5570.
24. Oh N, Park JH. Endocytosis and exocytosis of nanopar-
ticles in mammalian cells. Int J Nanomedicine. 2014; 9 
Suppl 1: 51-63.
25. Berry CC, Wells S, Charles S, Curtis AS. Dextran and al-
bumin derivatised iron oxide nanoparticles: influence on 
fibroblasts in vitro. Biomaterials. 2003; 24(25): 4551-4557.
26. Pawelczyk E, Arbab AS, Chaudhry A, Balakumaran A, 
Robey PG, Frank JA. In vitro model of bromodeoxyur-
idine or iron oxide nanoparticle uptake by activated mac-
rophages from labeled stem cells: implications for cellular 
therapy. Stem Cells. 2008; 26(5): 1366-1375.
27. Naqvi S, Samim M, Abdin M, Ahmed FJ, Maitra A, 
Prashant C, et al. Concentration-dependent toxicity of 
iron oxide nanoparticles mediated by increased oxidative 
stress. Int J Nanomedicin. 2010; 5: 983-989.
28. Mahmoudi M, Serpooshan V, Laurent S. Engineered na-
noparticles for biomolecular imaging. Nanoscale. 2011; 
3(8): 3007-3026.
29. Kunzmann A, Andersson B, Vogt C, Feliu N, Ye F, Gabri-
elsson S, et al. Efficient internalization of silica-coated iron 
oxide nanoparticles of different sizes by primary human 
macrophages and dendritic cells. Toxicol Appl Pharmacol. 
2011; 253(2): 81-93.
30. Singh Gaharwar U, Paulraj R. Iron oxide nanoparticles in-
duced oxidative damage in peripheral blood cells of rat. J 
Biomed Sci Eng. 2015; 8(4): 274-286.
31. Au KW, Liao SY, Lee YK, Lai WH, Ng KM, Chan YC, et al. 
Effects of iron oxide nanoparticles on cardiac differentia-
tion of embronic stem cells. Biochem Biophys Res Com-
mun. 2009; 379(4): 898-903.
32. Yanai A, Häfeli UO, Metcalfe AL, Soema P, Addo L, Greg-
ory-Evans CY, et al. Focused magnetic stem cell targeting 
to the retina using superparamagnetic iron oxide nanopar-
ticles. Cell Transplant. 2012; 21(6): 1137-1148. 
33. Vaněček V, Zablotskii V, Forostyak S, Růžička J, Herynek 
V, Babič M. Highly efficient magnetic targeting of mesen-
chymal stem cells in spinal cord injury. Int J Nanomedicin. 
2012; 7: 3719-3730. 
